The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Cholangitis, Sclerosing  [Clear All Filters]
2013
Sinakos, E., Samuel S., Enders F., Loftus E. V., Sandborn W. J., & Lindor K. D. (2013).  Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship.. Inflamm Bowel Dis. 19(5), 1004-9.
2012
Cholongitas, E., & Burroughs A. K. (2012).  Letter: ulcerative colitis in patients transplanted for primary sclerosing cholangitis.. Aliment Pharmacol Ther. 36(3), 296; author reply 297.
Sinakos, E., Abbas G., Jorgensen R. A., & Lindor K. D. (2012).  Serum lipids in primary sclerosing cholangitis.. Dig Liver Dis. 44(1), 44-8.
2011
Thackeray, E. W., Charatcharoenwitthaya P., Elfaki D., Sinakos E., & Lindor K. D. (2011).  Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis.. Clin Gastroenterol Hepatol. 9(1), 52-6.
Marelli, L., Xirouchakis E., Kalambokis G., Cholongitas E., Hamilton M. I., & Burroughs A. K. (2011).  Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?. Gut. 60(9), 1224-8.
Imam, M. H., Sinakos E., Gossard A. A., Kowdley K. V., Luketic V. A. C., M Harrison E., et al. (2011).  High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis.. Aliment Pharmacol Ther. 34(10), 1185-92.
Eaton, J. E., Silveira M. G., Pardi D. S., Sinakos E., Kowdley K. V., Luketic V. A. C., et al. (2011).  High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.. Am J Gastroenterol. 106(9), 1638-45.
Sinakos, E., Saenger A. K., Keach J., W Kim R., & Lindor K. D. (2011).  Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma.. Clin Gastroenterol Hepatol. 9(5), 434-9.e1.
2010
Sinakos, E., Marschall H-U., Kowdley K. V., Befeler A., Keach J., & Lindor K. (2010).  Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.. Hepatology. 52(1), 197-203.
Sinakos, E., & Lindor K. (2010).  Treatment options for primary sclerosing cholangitis.. Expert Rev Gastroenterol Hepatol. 4(4), 473-88.
2007
Zen, Y., N Adsay V., Bardadin K., Colombari R., Ferrell L., Haga H., et al. (2007).  Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria.. Mod Pathol. 20(6), 701-9.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.